HomeGLPG • AMS
add
Galapagos NV
Nakaraang pagsara
€23.16
Sakop ng araw
€22.90 - €23.34
Sakop ng taon
€22.00 - €37.17
Market cap
1.53B EUR
Average na Volume
122.65K
P/E ratio
7.35
Dividend yield
-
Primary exchange
AMS
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 59.85M | -50.14% |
Gastos sa pagpapatakbo | 21.09M | 112.58% |
Net na kita | -50.43M | -295.24% |
Net profit margin | -84.26 | -491.54% |
Kita sa bawat share | -0.74 | -289.74% |
EBITDA | -48.48M | -86.02% |
Aktuwal na % ng binabayarang buwis | 1.16% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.34B | -12.41% |
Kabuuang asset | 4.17B | -6.27% |
Kabuuang sagutin | 1.31B | -28.43% |
Kabuuang equity | 2.86B | — |
Natitirang share | 65.94M | — |
Presyo para makapag-book | 0.53 | — |
Return on assets | -3.21% | — |
Return on capital | -4.69% | — |
Cash Flow
Net change in cash
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -50.43M | -295.24% |
Cash mula sa mga operasyon | -71.79M | 39.58% |
Cash mula sa pag-invest | 56.56M | -69.02% |
Cash mula sa financing | -1.09M | 47.41% |
Net change in cash | -16.80M | -127.39% |
Malayang cash flow | -66.59M | 24.78% |
Tungkol
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Itinatag
1999
Website
Mga Empleyado
683
